Alpha Tau Medical Ltd. (DRTS)
- Previous Close
2.7600 - Open
2.8531 - Bid 2.7900 x 100
- Ask 2.8900 x 100
- Day's Range
2.8200 - 2.9000 - 52 Week Range
1.7500 - 4.3870 - Volume
26,555 - Avg. Volume
44,596 - Market Cap (intraday)
239.109M - Beta (5Y Monthly) 0.93
- PE Ratio (TTM)
-- - EPS (TTM)
-0.4500 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
8.75
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical or pending clinical studies for brain and other cancers. The company is headquartered in Jerusalem, Israel.
www.alphatau.comRecent News: DRTS
View MorePerformance Overview: DRTS
Trailing total returns as of 5/14/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: DRTS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: DRTS
View MoreValuation Measures
Market Cap
239.11M
Enterprise Value
192.04M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
3.82
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-23.27%
Return on Equity (ttm)
-43.16%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-31.75M
Diluted EPS (ttm)
-0.4500
Balance Sheet and Cash Flow
Total Cash (mrq)
59.6M
Total Debt/Equity (mrq)
20.00%
Levered Free Cash Flow (ttm)
-12.97M